Amidst the proliferation of training programmes, health professionals should examine the materials used in these packages, to ensure that they are truly designed to benefit patients.
An essential prerequisite for a training programme to be deemed reliable is that it be independent from all interests other than those of patients. But there are massive commercial stakes in the healthcare and pharmaceuticals field, as the prosecution of a US pharmaceutical company has demonstrated.
This trial exposed the firm’s strategy for promoting a drug beyond its approved clinical indications. The company’s internal documents reveal the methods pharmaceutical companies use to get their drugs prescribed. They show the central role that companies give to "continuing education", which they influence through funding and content provision. One company manager summed up this role in clear terms: "This market is driven by medical training".
The purpose of continuing education for health professionals is not to open up markets for drug companies, but to improve patient care. It is a pity that pharmaceutical companies have lost sight of this obvious fact.
©Prescrire June 2007
Source:
"Formations : vérifier les sources" Rev Prescrire 2007 ; 27 (284) : 401.
- More articles in Prescrire's "Spotlight"...